Cargando…
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype
Half of the myelodysplastic syndromes (MDS) have normal karyotype by conventional banding analysis. The percentage of true normal karyotype cases can be reduced by 20–30% with the complementary application of genomic microarrays. We here present a multicenter collaborative study of 163 MDS cases wit...
Autores principales: | Mallo, Mar, Tuechler, Heinz, Arenillas, Leonor, Raynaud, Sophie, Cluzeau, Thomas, Shih, Lee‐Yung, Tung‐Liang, Chiang, Ganster, Christina, Shirneshan, Katayoon, Haase, Detlef, Mascaró, Martí, Palomo, Laura, Cervera, José, Such, Esperanza, Trim, Nicola, Jeffries, Sally, Ridgway, Emma, Marconi, Giovanni, Martinelli, Giovanni, Solé, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188467/ https://www.ncbi.nlm.nih.gov/pubmed/37206269 http://dx.doi.org/10.1002/jha2.651 |
Ejemplares similares
-
Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes
por: Martin, Roman, et al.
Publicado: (2018) -
Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders
por: Schanz, Julie, et al.
Publicado: (2018) -
HomozygosityMapper—an interactive approach to homozygosity mapping
por: Seelow, Dominik, et al.
Publicado: (2009) -
HomozygosityMapper2012—bridging the gap between homozygosity mapping and deep sequencing
por: Seelow, Dominik, et al.
Publicado: (2012) -
Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine
por: Cluzeau, T, et al.
Publicado: (2013)